Evaluation of the ability of collagen-glycosaminoglycan scaffolds with or without mesenchymal stem cells to heal bone defects in Wistar rats. by Alhag, Mohamed et al.
Royal College of Surgeons in Ireland
e-publications@RCSI
Anatomy Articles Department of Anatomy
1-10-2011
Evaluation of the ability of collagen-
glycosaminoglycan scaffolds with or without
mesenchymal stem cells to heal bone defects in
Wistar rats.
Mohamed Alhag
Trinity College Dublin
E Farrell
Trinty College Dublin
M Toner
Trinty College Dublin
T Clive Lee
Royal College of Surgeons in Ireland
Fergal J. O'Brien
Royal College of Surgeons in Ireland, fjobrien@rcsi.ie
See next page for additional authors
This Article is brought to you for free and open access by the Department
of Anatomy at e-publications@RCSI. It has been accepted for inclusion in
Anatomy Articles by an authorized administrator of e-publications@RCSI.
For more information, please contact epubs@rcsi.ie.
Citation
Alhag M, Farrell E, Toner M, Lee TC, O'Brien FJ, Claffey N. Evaluation of the ability of collagen-glycosaminoglycan scaffolds with or
without mesenchymal stem cells to heal bone defects in Wistar rats. Oral and Maxillofacial Surgery. 2011 [epub ahead of print]
Authors
Mohamed Alhag, E Farrell, M Toner, T Clive Lee, Fergal J. O'Brien, and N Claffey
This article is available at e-publications@RCSI: http://epubs.rcsi.ie/anatart/48
— Use Licence —
Attribution-Non-Commercial-ShareAlike 1.0
You are free:
• to copy, distribute, display, and perform the work.
• to make derivative works.
Under the following conditions:
• Attribution — You must give the original author credit.
• Non-Commercial — You may not use this work for commercial purposes.
• Share Alike — If you alter, transform, or build upon this work, you may distribute the resulting work only
under a licence identical to this one.
For any reuse or distribution, you must make clear to others the licence terms of this work. Any of these
conditions can be waived if you get permission from the author.
Your fair use and other rights are in no way affected by the above.
This work is licenced under the Creative Commons Attribution-Non-Commercial-ShareAlike License. To
view a copy of this licence, visit:
URL (human-readable summary):
• http://creativecommons.org/licenses/by-nc-sa/1.0/
URL (legal code):
• http://creativecommons.org/worldwide/uk/translated-license
This article is available at e-publications@RCSI: http://epubs.rcsi.ie/anatart/48
 1 
Evaluation of the ability of collagen-glycosaminoglycan scaffolds with or without 
mesenchymal stem cells to heal bone defects in Wistar rats 
 
 
M. Alhag 
1* 
E. Farrell 
3, 4
  
 
M. Toner 
1
 
T. Clive Lee
 2, 3
  
F.J. O’Brien 2, 3 
N. Claffey 
1
  
 
 
1
School of Dental Science, Trinity College, Dublin, Ireland 
2
Department of Anatomy, Royal College of Surgeons in Ireland, Dublin, Ireland. 
3
Trinity Centre for Bioengineering, Trinity College, Dublin, Ireland 
4
Department of Orthopaedics, Erasmus University Medical Centre, Rotterdam, The           
Netherlands 
 
Running Title: Collagen scaffolds promote bone regeneration 
 
 
Correspondence to: 
Dr. Mohamed Alhag 
Division of Restorative Dentistry and Periodontology 
School of Dental Science 
Trinity College, Dublin 2, Ireland 
Email: alhagm@tcd.ie 
Tel:   +353-1-6127306 
Fax:   +353-1-6711255 
 
 
Key words: Collagen-glycosaminoglycan scaffold, Mesenchymal stem cells, 
Osteogenesis, Histology. 
 2 
Abstract 
Purpose The aim of this experiment was to examine the capacity of collagen-
glycosaminoglycan scaffolds, with or without mesenchymal stem cells, to 
satisfactorily repair a 5-mm rat calvarial defect.  
 
Methods 55 Wistar rats were used in the study. The defects were either left empty to 
serve as controls (n = 7), filled with cell-free scaffolds (n = 11), cell-seeded scaffolds 
that were pre-cultured in standard culture medium (n = 13), cell-seeded scaffolds that 
were pre-cultured in osteoinductive factor-supplemented medium (n = 12) or 
particulate autogenous bone (n = 12). The animals were sacrificed at 12 weeks after 
surgery and specimens were prepared for histomorphometric analysis. The linear bone 
healing and the bone area within the defect were measured.  
 
Results Comparable results were obtained using cell-free collagen-
glycosaminoglycan scaffolds and autogenous bone both in terms of linear bone 
healing (P<0.986) and area of new bone (P<0.846).  While the test groups showed 
significantly more bone formation compared to the empty defect control group, the 
linear bone healing and area of new bone within the defect were significantly lower in 
the cell-seeded scaffolds than in the cell-free scaffolds. The results have demonstrated 
that a cell-free collagen-glycosaminoglycan scaffold is capable of repairing a 5-mm 
rat calvarial defect as effectively as autogenous bone and that seeding the scaffold 
with pre-cultured mesenchymal stem cells prior to implantation offered no beneficial 
effect and resulted in incomplete healing of the defect.   
 
Conclusions The results thus suggest that the scaffold has immense potential for 
tissue repair showing favourable osteoconductive properties, biocompatibility and 
degradability. 
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Introduction 
Reconstruction of bony defects using autogenous bone grafting is widely considered 
the gold standard by which all techniques of osseous reconstruction of the cranio-
maxillofacial skeleton must be judged. However, both practitioners and patients have 
perceived this reconstructive method as being rather invasive, requiring bone removal 
from non-oral sites which may be associated with donor site morbidity. In order to 
eliminate the need to create a second surgical donor sites, recent studies have defined 
the field of scaffold-guided bone tissue engineering to be a promising strategy for the 
treatment of many skeletal defects [1]. Regenerative scaffolds allow for the 
repopulation and differentiation of various cell types and are the focus of many 
current investigations. 
 
There are two major approaches to tissue engineering for bone regeneration. One 
tissue engineering approach entails cell-free scaffolds in which the scaffold is used to 
act as a template for new tissue in-growth and to enhance the maturation and function 
of tissue that has been directed to grow into the scaffold. Cell-based tissue 
engineering approaches, on the other hand, incorporate seeding of a scaffold with 
cells that are delivered to and retained within the recipient site. In some cases, the 
cell/scaffold construct is pre-cultured in vitro to generate the required tissue and later 
transplanted to the recipient site [2]. Several studies have shown that the implantation 
of certain cell/scaffold combination can lead to better results in bone regeneration 
than the implantation of scaffolds alone [3]. 
 
A bone tissue engineering approach utilizing murine bone marrow-derived 
mesenchymal stem cells (MSCs) and collagen–glycosaminoglycan (CG) scaffolds has 
been investigated in our laboratory [4-6]. These studies have shown the ability of the 
CG scaffold to support the osteogenic differentiation of MSCs in vitro. The results 
demonstrated that MSCs can undergo osteogenesis followed by matrix deposition and 
mineralisation when grown on CG scaffolds and stimulated with osteoinductive 
factors (dexamethasone, ascorbic acid, and β-glycerophosphate), as evaluated by the 
temporal induction of the bone-specific proteins (collagen I and osteocalcin) and by 
evident mineral deposition when stained with alizarin red and von Kossa staining. 
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After in vitro proof-of-concept, we are interested in the current study in studying the 
behaviour of this tissue-engineered mineralized construct in vivo. 
  
Although a large number of materials have been developed for bone tissue 
engineering [7-9], only a few are currently being tested in critical size defects [10]. 
The aim of this study was to examine the capacity of CG scaffolds with or without 
MSCs to satisfactorily repair a critical sized defect in a rodent calvarium. The healing 
response of CG scaffolds is compared to that achieved by the “gold standard” 
autogenous bone graft. We are also interested in observing the difference between 
using osteoinductive factor-stimulated MSCs and non-stimulated MSCs.  
 
Material and methods 
Scaffold fabrication 
The CG scaffold was fabricated using a lyophilization (freeze-drying) method as 
detailed previously by O’Brien et al. [11].  Briefly, collagen type I from bovine 
tendon (Collagen Matrix, NJ, USA) was mixed with shark chondroitin 6-sulfate in 
acetic acid. The slurry was then freeze-dried at -40°C. This forces the co-precipitate 
into the spaces between the growing ice crystals to form a continuous, 
interpenetrating network of ice and the co-precipitate. Sublimation of the ice crystals 
under a vacuum leads to the formation of a highly porous sponge with an average 
pore size of 96 μm [12-13]. To stiffen and sterilize the collagen network, the scaffold 
was crosslinked using dehydrothermal processing at 105°C. 
 
Cell culture and scaffold seeding  
Under Irish Government License, MSCs were isolated from the bone marrow of adult 
male Wistar rats (250–350 g) as detailed in Farrell et al. [4].  MSCs were expanded 
for 3 weeks in a pre-warmed Dulbecco’s modified Eagle’s medium (DMEM, Sigma-
Aldrich, UK) supplemented with 10% fetal bovine serum, 100 U/ml of 
penicillin/streptomycin, 2 mM Glutamax, 1 mM of L-glutamine, and 1% nonessential 
amino acids (all from GIBCO, supplied by Biosciences, Dublin, Ireland). Medium 
was replaced every 3–4 days.  
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Previous work in our laboratory has demonstrated the presence of undifferentiated 
MSCs when bone marrow cells were isolated and cultured according to the above 
protocol [4-5]. Cells analyzed displayed positive endoglin immunoreactivity. 
Endoglin (CD105) is a cell surface marker of MSCs which has been used to 
distinguish between haematopoietic stem cells and MSCs [14]. Furthermore, 
Fluorescence-activated cell sorter (FACS) analysis verified that the cell population 
expressed high levels of the putative MSC surface marker CD90 [15], in agreement 
with previous published data on MSC cell surface markers [16]. The purity of the 
MSC population used in these experiments was concluded to be comparable with that 
used by others [17].  
 
To seed the CG scaffolds, cells were rinsed with phosphate-buffered saline, detached 
with trypsin-ethylenediaminetetraacetic acid (EDTA) solution and centrifuged at 650g 
for 5 min at 20°C. The resulting pellet was re-suspended in a 2-ml pre-warmed culture 
medium, and a single-cell suspension was obtained by aspirating through a 20-gauge 
needle. The cells were counted and diluted to achieve a cell density of 1x10
6
 cells/ml.  
Discs of CG scaffolds (16-mm in diameter) were seeded with 300 µl of cell 
suspension and incubated for 30 min at 37°C.  The scaffolds were then overturned 
onto agarose-coated wells, and a further 300 µl of cell suspension was placed onto the 
scaffold. After 30 min, 2 ml of culture medium was added to each well and the 
scaffolds were submerged. To induce osteogenic differentiation, scaffolds were 
placed in osteoinductive factor–supplemented medium containing 0.68 nM of 
dexamethasone, 10 mM of β-glycerophosphate, and 50 µM of ascorbic acid (Sigma-
Aldrich, UK). Non-seeded scaffolds to be used as controls were maintained in 
standard culture medium. Half of the respective media were replaced every 3 days. 
Scaffolds were maintained for 4 weeks in a humidified atmosphere of 95% air/5% 
CO2 at 37°C. 
 
Surgical Procedure 
In this study, 55 adult male Wistar rats (250–350 g) were used. The care and use of 
animals were in accordance with the ethical principles for animal research established 
by the Department of Health in Ireland. Anaesthesia was achieved with a mixture of 
75mg/kg of xylazine hydrochloride (Rompun®, Bayer Healthcare, Germany) and 10 
mg/kg of Ketamine hydrochloride (Vetalar™, Pharmacia Animal Health Ltd, UK) at a 
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dose of 0.2 ml/100 g body weight given intraperitoneally. The skin of the head was 
shaved and disinfected with 10% aqueous povidone-iodine solution (Seton, 
Healthcare Group Plc, England). To expose the calvarial bone a 1.5-cm vertical skin 
incision was made, and periosteum was carefully reflected. A standardized, circular, 
and transosseous defect, measuring 5-mm in diameter, was created on the parietal 
calvarial bone using a saline-cooled trephine drill at low rotational speed. The circular 
bone plug was gently removed, and care was exercised to avoid injury to the dura 
matter. To prepare the autogenous bone graft, the trephined calvarium was manually 
ground with a # 11 blade and collected in a sterile glass dappen dish. The harvesting 
of particulate autogenous bone resulted in predominantly cortical bone chips of 
various shapes and sizes.  
 
The defects were rinsed with normal saline and filled with graft material (Figure 1) in 
each experimental group as follows:  
Group 1 (n = 7) - The defects were left empty to serve as a control. 
Group 2 (n =11) - Cell-free scaffolds  
Group 3 (n = 13) - Cell-seeded scaffolds maintained in standard DMEM. 
Group 4 (n = 12) - Cell-seeded scaffolds maintained in osteoinductive factor-
supplemented DMEM. 
Group 5 (n =12) - Particulate autogenous bone. 
 
 
 
 
 
Figure 1. Surgical procedure: (a) Preparing the surgical defect. (b) 5-mm critical 
sized defect in the rat calvarium. (c) Placement of CG scaffold. (d) Closure of the 
overlaying periosteum 
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The overlaying periosteum and skin flaps were then closed using absorbable sutures 
(Ethicon™, NJ, USA). For the duration of the recovery period, animals were housed 
in the Bioresources Unit, Trinity College, Ireland under veterinary supervision. 
 
Histological Preparation 
Animals were sacrificed by CO2 asphyxiation at 12 weeks after surgery. Block 
sections, including the surgical sites, were removed and fixed in 10% neutral buffered 
formalin. Samples were decalcified in EDTA and embedded in paraffin. Before the 
embedding procedure, an incision was made exactly through the middle of the bone 
defects to ensure that the microtome sections were made in the area of interest. 
Coronal sections of 5-m thickness were cut through the centre of the defect and 
stained with haematoxylin and eosin (H & E).  
 
From each animal, three representative H & E-stained sections were randomly 
selected for histomorphometric analysis. Computer-assisted measurements were 
obtained using image analysis software (Analysis
®
 Soft Imaging System GmbH, 
Germany). Sections were analyzed under light microscopy (x10 magnification). All 
measurements were made by an examiner who was blinded with regard to treatment.  
 
Results 
All animals survived the surgical procedures and were available for evaluation. 
Wound healing progressed without any signs of infection, material exposure or other 
complications during the healing period and at the time of retrieval. Weight gain was 
normal in all animals.  
 
Qualitative histological analysis 
Group 1: The empty defect group demonstrated only a small amount of new bone 
which was confined to areas at the edge of the defect with no new bone formation in 
the other defect areas. Bone at the margins of the defect showed a mixture of lamellar 
and woven bone indicating persistent new bone formation. In most of the specimens, 
the central part of the defect healed with a thin connective tissue as shown in Figure 2. 
There was no sign of inflammatory infiltrates throughout the surgical defect. 
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Group 2: The implantation of the cell-free scaffold resulted in extensive new bone 
formation apparent in all of the defects. Microscopically no residues of the CG 
scaffold were found after 12 weeks. At the defect margins, the newly formed bone 
appeared well integrated with the host bone. A thickening of bone at the bony margin 
of the defect was also observed. The outer surface of the new bone that faced the 
scalp and the inner surface that faced the dura mater demonstrated a mature lamellar 
bone, while the middle part of the new bone demonstrated a woven bone pattern with 
increased haematopoietic stromal areas (Figure 3).  
 
 
 
 
 
 
 
 
 
Figure 2. Representative micrograph of the empty defect group showing a thin layer 
of connective tissue occupying the defect. H & E stained. Arrow = defect margin. (a) 
Original magnification x1.25. (b) Original magnification x10 
 
 
 
 
 
 
 
Figure 3. (a) Micrograph showing marked bone formation within defects treated with 
cell-free scaffolds. Arrows indicating the edges of host bone. Original magnification 
x1.25. (b) Micrograph showing good integration and bone thickening ar the interface 
between host and new bone. (1) Lamellar bone. (2) Woven bone. H & E stained. 
Original magnification x4. 
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Group 3: The overall extent of bone regeneration in this group (cell-seeded scaffolds 
that were cultured in standard medium) was limited. Areas of new bone were evident 
at the margins and towards the centre of the defects. In most of the examined sections, 
there was no solid osseous bridging of the defect, but islands of bone were distributed 
in the former defect area and embedded in a fibroblast-rich connective tissue that was 
organized and dense. However, new bone formation, originated from the margins 
and/or as bone isles throughout the defect, was greater than in the empty defect group. 
The newly formed bone in the centre of the defect appeared lamellar in nature with 
mature osteocytes (figure 4).  
 
Group 4: The defects which were grafted with MSC-seeded scaffolds that were 
cultured in the presence of osteoinductive factors showed similar healing pattern to 
those cultured in standard culture medium (figure 5). The extent of bone regeneration 
in this group was less than the new bone seen with non-seeded scaffolds. 
 
Group 5: In animals that received particulate autogenous bone, the defect was 
completely filled by new bone. The grafted bone particles did not exhibit signs of 
significant degradation and remnants of grafted chips were evenly distributed within 
the defect area. Similar to the defect margins, the graft surfaces were lined to a large 
extent by layers of new bone that bridged the gaps between the particles and 
connected them to the defect walls. The newly formed bone appeared less mature than 
the implanted bone particles, as demonstrated by the disorganization of its bone 
lamellae and osteocytes.  Most defects were completely filled with bone which 
exhibited a cortical structure close to the surface, and was rather cancellous towards 
the centre of the defect with wide intra-trabecular spaces, collagen fibres and blood 
vessels. Close to the newly formed bone tissue margins and the graft fragments, there 
were numerous osteoblasts characterizing areas with intense bone apposition (Figure 
6). 
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Figure 4. H & E stained representative micrographs of the cell-seeded scaffolds 
(group 3). (a) Defect healing by islands of new bone embedded in connective tissue. 
Original magnification x2.  (b) Mature lamellar bone. Original magnification x10. 
 
 
 
 
Figure 5. H & E stained representative micrographs of the cell-seeded scaffolds 
(group 4). (a) Defect healing by islands of new bone embedded in connective tissue. 
Original magnification x2.  (b) Mature lamellar bone. Original magnification x10. 
 
 
 
 
Figure 6. (a) Micrograph exhibiting complete bone bridging in a defect grafted with 
particulate autogenous bone. (H & E stained. Original magnification x1.25). (b) A 
close-up view of the newly formed bone, exhibiting graft particles (1) surrounded by 
less mature new bone (H & E stained, original magnification x10). 
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Histomorphometric and statistical analyses 
Histomorphometric parameters were defined as follows: 
 Percentage of linear bone healing in the defect. 
 Area of new bone in the defect. 
 
(A) Measurement of percentage of linear bone healing in the defect. 
The percentage of new bone in the defect was evaluated to determine which treatment 
was able to facilitate bony bridging of the defect. Similar levels of linear bone healing 
were found in surgical defects that received cell-free collagen-GAG scaffolds (93.52 
±2.42) when compared to particulate autogenous bone (94.70 ±1.24). On the other 
hand, the cell-seeded scaffolds in group 3 and group 4 resulted in a mean percentage 
of bone healing of (74.21 ±3.59) and (76.78 ±4.10) respectively. Defects which were 
left empty showed the least mean percentage of bone healing of (65.45 ±5.21). Figure 
7 illustrates the mean percentage of bone healing amongst the study groups by the end 
of 12 weeks in vivo. 
 
Analysis of variance (ANOVA) showed no significant difference between the bone 
healing in the cell-free scaffold (group 2) and the autogenous bone (group 5) 
(P<0.986). However, the bone healing in the cell-free scaffold group was found to be 
significantly greater than the bone healing achieved by the rest of the study groups 
(P<0.0001). The test showed no difference between the bone healing generated by the 
cell-seeded scaffolds that were cultured in standard culture medium (group 3) and the 
bone healing by the cell-seeded scaffold that were cultured in presence of 
osteoinductive factors (group 4) (P<0.774).  
 
(B) Area measurement of newly formed bone within the defect. 
The average bone area within the defect per group after 12 weeks in vivo is shown in 
figure 8. Defects which were left empty showed the least mean value of bone area 
(1.04 ±0.079). On the other hand, a higher mean value of bone area was seen in the 
defects that were grafted with cell-free collagen-GAG scaffold (1.59 ±0.12). This was 
similar to the mean bone area measured in autogenous bone group (1.66 ±0.08). The 
cell-seeded scaffolds in group 3 and group 4 resulted in a mean value of bone area of 
(1.13 ±0.07) and (1.28 ±0.07) respectively. 
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Statistical analysis of the mean bone area in the cell-free scaffold (group 2) and the 
autogenous bone (group 5) showed similar effects (P<0.846). The bone area in the 
cell-free scaffold group, however, was found to be significantly greater than the bone 
area achieved by the rest of the study groups (P<0.0001). The test showed that the 
bone area generated by the cell-seeded scaffolds that were cultured in standard culture 
medium (group 3) and the bone area by the cell-seeded scaffold that were cultured in 
presence of osteoinductive factors (group 4) did not significantly differ (P<0.115).  
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Discussion 
The aim of this investigation was to assess the ability of MSC-seeded CG scaffolds 
that were pre-cultured in vitro for 4 weeks to regenerate bone tissue in a 5-mm rat 
calvarial defect. We also compared the healing response of the CG scaffolds to 
autogenous bone. Following a healing period of 12 weeks, comparable results of 
complete bone healing were obtained using cell-free CG scaffolds and autogenous 
bone. While all the test groups showed significantly more bone formation compared 
to the empty defect control group, the percentage of bone healing and bone area 
within the defect were significantly lower in the cell-seeded scaffolds than in the cell-
free scaffolds. 
 
We assessed bone healing 12 weeks after surgery, considering that bone healing 
might plateau between 4 to 12 weeks after surgery. Additional healing over an 8-week 
time frame was described by Gasain et al. [18], and for that reason we sacrificed all 
animals at 12 weeks after surgery considering the potential healing between 8-week 
and 12-week time frame. No additional healing is expected after the 12-week time 
point as previously showed by Nguyen et al. [19]. We defined long-term evaluation as 
the longest period of postoperative care during which bone formation had stopped and 
no additional healing would be found. Thus, a 12-week time point was the optimal 
time to evaluate the clinical consequences and side effects of cell-free and cell-seeded 
CG scaffolds. 
 
In the control group, where the defects were left empty, the central part of the defect 
healed with a thin connective tissue. This demonstrated that 5-mm calvarial defect 
was of a critical size (non healing within the length of the study). This is in line with 
the results of several previous studies [20-23]. The bone healing in the test groups was 
found to be significantly higher than the bone healing achieved by the empty defect 
group (P<0.0001).  
 
The cell-free scaffolds facilitated bony healing of the defect similar to autogenous 
bone and significantly more new bone formation than all the other groups, both in 
terms of bone area and bony bridging of the defect. In a previously published work we 
demonstrated the tissue compatibility and the ability of cell-free CG to provide a 
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scaffold which allows infiltration of host cells [24]. Its full mineralization after 12 
weeks of implantation is a further proof of its osteoconductive properties. The newly 
formed bone appeared well integrated with the host bone with a bony thickening at 
the interface. The scaffold appeared completely degraded and replaced by new bone. 
This is an extremely important property of scaffolds used for bone regeneration. It has 
been reported in previous studies that type I collagen had been resorbed and 
substituted by mature bone 9 weeks after implantation [25].  The authors of that study 
concluded that this histological sequence was ideal for induction of osteogenesis.  
 
The CG scaffold might have played a role in the early cell proliferation, 
differentiation and subsequent secretion of extracellular matrix. Petrovic et al. [26] 
studied the suitability of different alloplastic and xenogenic biomaterials as scaffolds 
for ex vivo osteoblast cultivation. The authors concluded that a 3-dimensional 
collagen type-I scaffold can provide a more favorable environment for the attachment, 
proliferation, and differentiation of in vitro osteoblast-like cells, at least until the 
initial stage of differentiation, than non collagenous biomaterials. Mizuno et al. [27] 
demonstrated that bone marrow stromal cells expressed osteoblastic phenotypes (high 
alkaline phosphatase activity and synthesis of osteocalcin), when they were 
maintained on type I collagen matrix gel in vitro, and formed bone in the 
subcutaneous region of nude mice in vivo. According to our knowledge, however, we 
are the first to report on the use of CG scaffold for bone regeneration in an in vivo 
setting. 
 
The use of autogenous bone graft resulted in extensive new bone formation within the 
defect. The deposition of woven bone was not only observed on the exposed defect 
walls, but also extensively on the graft surfaces. This confirmed the excellent 
osteoconductive properties of autograft. Studies have shown that autogenous bone 
graft gives the best post bone grafting results [28]. In a study on miniature pigs, Buser 
et al. [29] compared autogenous bone to DFDBA, tricalcium phosphate, and coral-
derived hydroxyapatite. After 4 weeks of healing, they found that autologous bone 
graft had the best bone regenerative properties during the initial healing period with 
39% of newly formed bone inside the membrane-covered defect.  
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The cell-seeded scaffolds showed greater new bone formation than the empty defect 
group but significantly less than the cell-free scaffold. Islands of newly formed bone 
immersed in loose fibrous connective tissue were distributed throughout the defect but 
complete bony bridging was not seen in most of the animals. Interestingly, 
comparable levels of new bone were produced by MSC-seeded scaffolds that were 
pre-cultured in standard culture medium and those pre-cultured in the presence of 
osteoinductive factors. 
 
The findings of our previously published in vivo experiment may provide an 
explanation to the lack of continuous bony bridging of the defects grafted with MSC-
seeded scaffolds [24]. In particular, inflammation induced initially after scaffold 
implantation has been linked with unsuccessful engraftment of tissue-engineering 
constructs [30-31]. A foreign body reaction to the implanted MSC-seeded scaffold 
may have resulted in premature scaffold degradation [32]. If degradation is too rapid, 
osteoblasts will be deprived of a surface on which to migrate and secrete bone matrix, 
the result being fibrous repair rather than osseous regeneration. To ensure optimal 
healing and incorporation results, the augmentation material must not generate a 
specific immune response of the host cells, with initiation of chemotaxis, activation 
and proliferation [33]. 
 
Cell-mediated contraction of CG scaffolds is another possible explanation for the 
interrupted pattern of bone formation in MSC-seeded scaffolds. Because of the 
contraction of cell-seeded scaffolds, changes in the size and microstructure of the 
implants take place frequently. Cell-mediated contraction can collapse the pores of the 
scaffold, thereby possibly affecting cell migration and proliferation and the flow of 
nutrients, and can distort the shape of the construct [34-35]. A change in size will 
cause difficulty in fitting a specific implant site, or cause separation from the 
surrounding tissue host [36-37]. Furthermore, in vivo deformation of the scaffold 
could result in a loss of contact between the implanted device and the host tissue, 
thereby decreasing the chances for successful integration of the repair tissue. 
 
A limitation of the present study is that the MSCs used were not labelled and thus 
could not be distinguished from the infiltrating host-derived cells. As such, the 
possibility that the newly formed bone in the cell-seeded scaffolds was laid by the 
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infiltrating host-derived cells cannot be ruled out. Accordingly, because new bone 
formed in the cell-free grafted defects, it seems that the host cells which populated the 
cell-free scaffold were able to initiate new bone filling of the defect without the aid of 
implanted MSCs. These findings are in conflict with other studies, in which it has 
been reported that implants with differentiated osteoblasts and developed matrix are 
not only involved in direct bone formation, but also appear to be osteoinductive, 
inducing differentiation of host mesenchymal cells into osteoprogenitor cells during 
repair of the critical-size bone defects [38-40].  
 
It has been reported previously that both delivery and migration of osteoprogenitor 
cells into bone defect areas establish the most definitive reconstruction of bone 
defects [41-42]. Potentially, these cells secrete specific extracellular matrix 
components [43], which could induce proliferation and differentiation of 
mesenchymal cells into osteoblasts and result in the formation of new bone [44]. The 
above-described findings implicate an active role for implanted osteoblasts in bone 
repair; however, in our study, cell-free CG scaffolds resulted in mineralization not 
only on collagen fibrils, but also within newly formed extracellular matrix. Such 
mineralization was significantly decreased in CG scaffolds seeded with MSCs.  
 
Conclusions 
We have demonstrated that grafting a 5-mm rat calvarial defect with cell-free CG 
scaffold results in a complete bone healing comparable to that achieved by 
autogenous bone. The scaffold showed favorable osteoconductive properties, 
biocompatibility and degradability. In addition, we found that using pre-cultured 
MSC-seeded CG scaffolds resulted in incomplete healing of the defect. Irrespective of 
these findings there is a need to determine the precise role of implanted vital cells in 
the mineralization process and what role, if any, the implanted cells play in the 
induction of mineralization in vivo.  
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